Evidence map›Paper›PMID 26340537›Full record

ArticlePloS one2015

Functional Impact of 14 Single Nucleotide Polymorphisms Causing Missense Mutations of Human α7 Nicotinic Receptor.

Qinhui Zhang, Yingjie Du, Jianliang Zhang, Xiaojun Xu, Fenqin Xue, Cong Guo, Yao Huang, Ronald J Lukas, Yongchang Chang

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qinhui ZhangDepartment of Zoology, College of Life Sciences, Sichuan University, Chengdu, Sichuan Province, 610064, China; Chengdu institute of Biology, Chinese Academy of Sciences, Chengdu, Sichuan 610041, China; Division of Neurobiology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013, United States of America.
Yingjie DuUniversity of California Los Angeles, Henry Samueli School of Engineering and Applied Science, Los Angeles, California 90095, United States of America.
Jianliang ZhangDivision of Neurobiology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013, United States of America; Department of Neurobiology, Beijing Institute of Brain Disorders, Capital Medical University, Key Laboratory for Neurodegenerative Disease of the Ministry of Education, Beijing Center of Neural Regeneration and Repair, Beijing Key Laboratory of Brain Major Disorders; State Key Lab Incubation Base, Beijing Neuroscience Disciplines, Beijing 100069, China.
Xiaojun XuDivision of Neurobiology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013, United States of America.
Fenqin XueDivision of Neurobiology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013, United States of America; Core Facilities for Electrophysiology, Core Facilities Center, Capital Medical University, Beijing 100069, China.
Cong GuoDepartment of Zoology, College of Life Sciences, Sichuan University, Chengdu, Sichuan Province, 610064, China; Chengdu institute of Biology, Chinese Academy of Sciences, Chengdu, Sichuan 610041, China.
Yao HuangDepartment of Obstetrics and Gynecology, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013, United States of America.
Ronald J LukasDivision of Neurobiology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013, United States of America.
Yongchang ChangDivision of Neurobiology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013, United States of America.

Funding

Structural dynamics underlying rho1 GABAC receptor activation and antagonismR01GM085237 · NIGMS · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · PI CHANG, YONGCHANG · 2010 to 2014
$1.2M
NIGMS NIH HHS R01 GM085237NIGMS NIH HHS R01GM085237
6 · The paper itself

Abstract

The α7nicotinic receptor (nAChR) is a major subtype of the nAChRs in the central nervous system, and the receptor plays an important role in brain function. In the dbSNP database, there are 55 single nucleotide polymorphisms (SNPs) that cause missense mutations of the human α7nAChR in the coding region. In this study, we tested the impact of 14 SNPs that cause missense mutations in the agonist binding site or the coupling region between binding site and channel gate on the receptor function. The wild type or mutant receptors were expressed or co-expressed in Xenopus oocytes, and the agonist-induced currents were tested using two-electrode voltage clamp. Our results demonstrated that 6 mutants were nonfunctional, 4 mutants had reduced current expression, and 1 mutants altered ACh and nicotine efficacy in the opposite direction, and one additional mutant had slightly reduced agonist sensitivity. Interestingly, the function of most of these nonfunctional mutants could be rescued by α7nAChR positive allosteric modulator PNU-120596 and agonist-PAM 4BP-TQS. Finally, when coexpressed with the wild type, the nonfunctional mutants could also influence the receptor function. These changes of the receptor properties by the mutations could potentially have an impact on the physiological function of the α7nAChR-mediated cholinergic synaptic transmission and anti-inflammatory effects in the human SNP carriers. Rescuing the nonfunctional mutants could provide a novel way to treat the related disorders.

Indexed as

Mutation, MissensePolymorphism, Single NucleotideAcetylcholineAllosteric Regulationalpha7 Nicotinic Acetylcholine ReceptorAnimalsDose-Response Relationship, DrugGene ExpressionHumansIsoxazolesModels, MolecularNicotineNicotinic AgonistsOocytesPatch-Clamp TechniquesPhenylurea Compounds1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)urea4-(4-bromophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinoline-8-sulfonamideAcetylcholinealpha7 Nicotinic Acetylcholine ReceptorIsoxazolesNicotineNicotinic AgonistsPhenylurea CompoundsQuinolinesSulfonamides

Identifiers

PMID26340537
PMCPMC4560414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.